INTRODUCTION
Receptor-mediated hydrolysis of phosphoinositides is a common cellular response to a variety of extracellular stimuli such as hormones, neurotransmitters and certain growth factors (Michell et al., 1981;  Berridge, 1984) . There is now general agreement that receptor stimulation induces the phosphodiesteratic cleavage of Ptdlns(4,5)P2, resulting in the formation of at least two second messengers: diacylglycerol, an activator ofprotein kinase C (Nishizuka, 1983) , and Ins(1,4,5)P3, which triggers the release of Ca2+ from intracellular stores (Berridge & Irvine, 1984) . It has recently become clear that in addition to Ins(1,4,5)P3, stimulated cells also produce Ins(1,3,4)P3 Burgess et al., 1985) and Ins(1,3,4,5)P4 (Batty et al., 1985; Heslop et al., 1985) via a pathway that apparently involves a specific Ins(1,4,5)P3 3-kinase (Irvine et al., 1986) , but whether these novel inositol phosphates have a second messenger role in Ca2+ signalling remains to be established.
In a recent study we have investigated the Ca2+-mobilizing mechanisms of epidermal growth factor (EGF) in human A431 epidermoid carcinoma cells (Moolenaar et al., 1986) for which EGF-induced phosphoinositide turnover had previously been described (Sawyer & Cohen, 1981) . In a further series of experiments we found that the nonapeptide bradykinin (Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg) not only is much more potent than EGF in raising [Ca2+]i and inositol phosphate levels, but, unlike EGF, also stimulates DNA synthesis and cell division in A431 cells (W. H. Moolenaar & B. C. Tilly, unpublished work) . Hence, bradykinin-activated A431 cells serve as a useful system to unravel the complex metabolism of inositol phospholipids and to examine their role in the control of cell proliferation.
In the present study we report the rapid formation of inositol phosphates in A431 cells stimulated with bradykinin. Complete separation of the individual inositol phosphates was obtained, allowing detailed analysis of their production and comparison with the time course of the Ca2+ signal. 
MATERIALS AND METHODS

Chemicals
Bradykinin was obtained from Sigma, pertussis toxin from List Laboratories (Campbell, CA, U.S.A.) and quin-2 acetoxymethyl ester from Calbiochem. All chemicals used were analytical grade.
Celi culture
Human A431 epidermoid carcinoma cells (obtained from Dr. G. Todaro) were grown in DMEM (Gibco) supplemented with 7.5% (v/v) fetal calf serum. The cells were plated on 35 mm culture dishes (Costar) and grown to near confluency before being used in the experiments.
Determination of total inositol phosphates
Cells were prelabelled to near isotopic equilibrium with 4,Ci of [3H]inositol/ml for 24 h. At 2 h prior to stimulation the cells were incubated in serum-free DMEM containing 20 mM-Hepes (pH 7.4). The cells were stimulated with bradykinin in the presence of 10 mM-LiCl for various periods and the incubations were terminated by replacing the medium by 1 ml of 10% trichloroacetic acid. After 10 min the extracts, containing the inositol phosphates, were collected and the trichloroacetic acid was removed by washing four times with 2 vol. of water-saturated diethyl ether. The samples were neutralized by adding Tris base, diluted to 4 ml with distilled water and placed on an AG 1X8 column (200-400 mesh, formate form; Bio-Rad) with a bed volume of 250,l. After eluting the column with 2 ml of water and 5 ml of 60 mM-ammonium formate/5 mM-sodium tetraborate, to remove inositol and glycerophosphoinositol, an inositol phosphate fraction was obtained by eluting five times with 2 ml of 1.0 M-ammonium formate/0. 1 Mformic acid. This inositol phosphate fraction (InsP. fraction) consists of InsPl, InsP2 and InsP3 (Berridge et al., 1982) .
Separation of inositol phosphates by h.p.l.c.
To investigate inositol phosphate metabolism the cells were prelabelled with 15 ,Ci of myo-[2-3H]inositol/ml for 24 h. The cells were stimulated with bradykinin in the absence of LiCl and samples were prepared as described above. EGTA and mannitol was added to the neutralized samples to a final concentration of 1 mm and 50 /LM, respectively. Inositol phosphates were separated by h.p.l.c. an'ion-exchange chromatography according to a modification of the method described by Irvine et al. (1985) , using a weakly basic anion exchange column (Nucleosil 10 NH2; 4 mm x 250 mm; Macherey-Nagel). The column was eluted with a 45 ml linear gradient to 1.5 M-ammonium formate/phosphoric acid (pH 3.7), started after 10 ml of distilled water, at a flow rate of 1.25 ml/min. Adenine nucleotides (AMP, ADP and ATP) were added to the samples. The column was calibrated with 3H-labelled inositol phosphates [Ins(I)P, Ins(1,4)P2 and Ins(1,4,5)P3; Amersham]. A264 was monitored. For determination of the inositol phosphates (except for InsP3), 625,ul (0.5 min) fractions were taken. To quantify the 3H radioactivity in Ins(1,3,4)P3 and Ins(1,4,5)P3 125,l (0.1 min) fractions were collected. 3H radioactivity was determined by liquid-scintillation counting, using Instagel (Packard)/methanol/water (10: 1: 1, by vol.) as counting fluid (Heslop et al., 1985) .
Quin-2 fluorescence
Nearly confluent A431 monolayers, attached to rectangular glass coverslips, were loaded with quin-2 by incubating them in serum-free DMEM containing 10 M-quin-2 ester for 30 min at 37 'C. Fluorescence from the quin-2-loaded cells was continuously monitored in a Perkin-Elmer model 3000 spectrofluorometer, as previously described (Moolenaar et al., 1986) . For calibration procedures and other experimental details see Moolenaar et al. (1984 Moolenaar et al. ( , 1986 .
RESULTS
Bradykinin-induced formation of inositol phosphates
Addition of bradykinin to nearly confluent cultures of A431 cells in the presence of 10 mM-LiCl causes a dose-dependent accumulation of inositol phosphates (Fig. 1) . Half-maximal stimulation occurs at a concentration of 4 nm, which is close to the reported Kd for
[3H]bradykinin-receptor binding in various mammalian tissues (Innis et al., 1981) , while a saturating response is observed at approx. 1 M. At this concentration the inositol phosphate level is 3-4-fold that of the basal level. The stimulatory effect of bradykinin on inositol phosphate formation is very rapid (Fig. 2 ). Within 15 s of hormone stimulation, a 2-3-fold increase in inositol phosphates is measured. An apparent saturation of inositol phosphate accumulation occurs in less than 2 min. After that period no further production of inositol phosphates is detectable, despite the continuous presence of the hormone. The time-course of formation and degradation of [3H]inositol phosphates extracted from A431 cells was analysed by means of h.p.l.c. anion-exchange chromatography. After eluting the column with a linear gradient of 0-1.5 M-ammonium formate/phosphoric acid (pH 3.7) at least ten peaks can be observed (Fig. 4) . Ins(I)P, Ins(1,4)P2 and Ins(1,4,5)P3 were identified by adding purified 3H-labelled inositol phosphates (Amersham) to the samples. Some variation in the basal levels (1984, 1986 ).
( Fig. 3) . Measurements of inositol phosphates in the presence of 10 mM-LiCl demonstrate that a rapid production of inositol phosphates take place after addition of bradykinin ( Figs. 1 and 2 ). H.p.l.c. analysis shows that the levels of the various inositol phosphates are markedly increased after stimulation with bradykinin for 30 s ( ( Fig. 6 ). Unlike the increase in Ins(1,4,5)P3, the formation of InsP4 (about 10 times the basal level) is not transient, but is sustained over a much longer period; an approx. 6-fold stimulation is still measured 10 min after e rise in [Ca2+] , occurs bradykinin addition. Fig. 5 shows that the increase in (< 1 s) and reaches a InsP2 (approx. 4-fold) declines slowly and reaches basal ; a 4-5-fold increase in levels after 2-10 min.
isient, decreasing to the As with other stimulated cells, the accumulation of r bradykinin addition.
Ins(1,3,4)P, shows a distinct delay of approx. 15 s ( (Fig. 6) . The mean decrease in InsP5 at the 15 s time-point is 15+5% (n = 3; P < 0.05 relative to the control).
Effects of pertussis toxin
In some cell types, there is evidence that a pertussis toxin-sensitive GTP-binding protein is involved in the coupling of hormone receptors to the hydrolysis of phosphoinositides (e.g. Nakamura & Ui, 1985; Volpi et al., 1985) . To test the effects of this bacterial toxin on bradykinin-stimulated inositol phosphate formation, the cells were incubated for 2 h in a medium containing 200 ng of pertussis toxin/ml. (Fig. 7) .
DISCUSSION
Our results provide the first evidence that the neuropeptide bradykinin stimulates inositol phosphate formation and raises free Ca2+ in human A431 cells, apparently through interaction with a specific membrane receptor, as previously reported for other cell systems (Pidikiti et al., 1985; Yano et al., 1985; Derian & Moskowitz, 1986) . While the A431 cell line has been widely exploited for EGF-receptor studies, its strong responsiveness to bradykinin is a useful and previously unsuspected property of this cell line.
The major aim of the present study was to unravel the complex metabolism of inositol phosphates in A431 cells and to monitor the kinetics of their formation in response to bradykinin.
Separation of the inositol phosphates by h.p.l.c. anion exchange chromatography demonstrates that, in addition to the identified Ins(I)P, Ins(1,4)P2 and Ins(1,4,5)P3, several other putative inositol phosphates are present in A431 cells. From their ionophoretic mobilities, and from previous analyses in other cells Heslop et al., 1985) we identify them as Ins(1,3,4)P3, InsP4, InsP5 and InsP6; however, our identification of the higher phosphorylated forms of inositol is as yet preliminary in that radiolabelled markers of these inositol phosphates are not available. It is worth mentioning that, by using a weakly basic anion-exchange column, we were able to elute all the inositol phosphate peaks at a relatively low ionic strength (linear gradient to 1.5 M-ammonium formate); nevertheless, we obtained a perfect separation of the various peaks comparable with the elution pattern described by Heslop et al. (1985) who used a gradient to 3.4 M.
The height of the putative InsP5 peak (> 40% of the total 3H radioactivity) is rather surprising. In the only previously published report of InsP5 and InsP6 in mammalian cells, Heslop et al. (1985) found that the amount of InsP5 in GH4 cells is only slightly higher than that of InsP4 and InsP6. The function and metabolism of InsP5 and InsP6 in mammalian cells are unknown, although it is clear that their concentrations do not change dramatically upon hormonal stimulation of cells, as shown here for bradykinin in A431 cells (Fig. 6 ) and as earlier reported for TRH in GH4 cells (Heslop et al., 1985) .
The bradykinin-induced alterations in the levels of
Ins (1, Batty et al. (1985) and further supported by the presence of Ins(1,4,5)P3 kinase in various mammalian tissues (Irvine et al., 1986) . Recently this pathway has also been demonstrated in isolated rat hepatocytes (Hansen et al., 1986) .
The rapid formation of Ins(1,3,4)P3 and InsP4 supports the proposal that, like Ins(1,4,5)P3, these inositol phosphates could function as second messengers. However, whatever their possible biological functions, the kinetics of their formation argues against a role in calcium mobilization in stimulated cells. Thus, while the Ca2+ signal is initiated without a detectable lag period (< 1 s) and reaches a peak within 20-30 s, the formation of both InsP4 and Ins(1,3,4)P3 is initiated only after a lag period of at least 15 s and reaches a peak at 30-60 s, when the Ca2+ signal is already declining. Furthermore, the increases in InsP4 and Ins(1,3,4)P3 levels are much less transient and outlast the [Ca2+]1 signal by more than 10min.
We note that, while InsP has returned to almost basal levels after 2 min, the levels of InsP2, Ins(1,3,4)P3 and InsP4 are still elevated. The amount of InsP2 declines slowly, reaching basal levels after approx. 10 min, whereas Ins(1,3,4)P3 and InsP4 levels remain elevated. This suggests that a new steady state for Ins(1,3,4)P3 and InsP4 has been reached at this time point. However, it is preliminary to draw definite conclusions as long as the nature of the rate-limiting steps in the metabolic degradation of InsP4 remain to be elucidated. The bradykinin response is hardly affected by pretreatment with pertussis toxin, indicating that the coupling between the receptor and the phosphodiesterase is not mediated by a pertussis toxin-sensitive GTPbinding protein. The small effects of pertussis toxin on both basal and agonist-stimulated inositol phosphate levels are perhaps attributable to an increase in cellular cyclic AMP levels (Takai et al., 1982; Sano et al., 1983) .
In the continuous presence of bradykinin, a saturation of inositol phosphate production occurs within 30-60 s (Fig. 6) . One possibility to explain this saturation phenomenon is a rapid depletion of the bradykininsensitive PtdInsP2 pool. A second possibility, for which there is some indirect support, is that the receptormediated phosphoinositide hydrolysis is under inhibitory control, perhaps through diacylglycerol-activated protein kinase C (cf. Brock et al., 1985; Orellana et al., 1985; Leeb-Lundberg et al., 1985) .
Since our preliminary experiments indicate that bradykinin is a mitogen for A431 cells, as it is for fibroblasts (Owen & Villereal, 1983; Straus & Pang, 1984) , and induces oncogene expression (W. Kruijen & W. H. Moolenaar, unpublished work), the present results raise the interesting possibility that Ins(1,3,4)P3 and/or InsP4 may somehow contribute to mitogenic signalling. In this respect it is noteworthy that exogenously added Li+ causes a pronounced accumulation of Ins(1,3,4)P3, at least in pancreatic acinar cells (Burgess et al., 1985) , while the stimulation of DNA synthesis by Li+ in various cell types is well documented (Hori & Oka, 1979; Ptashne et al., 1980; Rybak & Stockdale, 1981) . Further experiments are needed to investigate the relationship between Li+-induced inositol phosphate accumulation and cell proliferation.
Now that the effects of bradykinin on inositol phosphate formation in A431 cells have been examined in detail, it will be ofgreat interest to investigate the action of EGF on inositol phosphate metabolism and to compare it with that of bradykinin.
